Local anaesthetics
How local anaesthetics block voltage-gated sodium channels, how structure sets onset, potency and duration, why fibres are blocked differentially, why they fail in infected tissue, and the mechanisms behind systemic toxicity and its treatment principles.
By the end of this page you should be able to
- Describe the structure of a local anaesthetic molecule and explain the roles of the ionised and unionised forms.
- Explain how pKa, lipid solubility and protein binding relate to onset, potency and duration.
- Distinguish esters from amides by metabolism and allergy risk.
- Explain differential nerve blockade and why local anaesthetics fail in inflamed tissue.
- Describe the mechanisms of local anaesthetic systemic toxicity and the principle of lipid emulsion rescue.
- Explain the mechanisms behind added vasoconstrictors, methaemoglobinaemia and topical formulations.
Mechanism
Local anaesthetics are weak bases with three parts: a lipophilic aromatic ring, an intermediate chain that is either an ester or an amide, and a hydrophilic tertiary amine that can accept a proton.
They block voltage-gated sodium channels. The binding site is on the inner face of the pore, so the drug must first cross the axon membrane as the uncharged base, then re-ionise in the slightly more acidic axoplasm to the cation that actually blocks the channel. Blockade prevents the inward sodium current, so the membrane cannot reach threshold and the action potential fails to propagate. The resting potential itself is unchanged.
Binding is state-dependent: the drug has a much higher affinity for the open and inactivated channel than for the resting closed channel. Blockade therefore accumulates in fibres that are firing rapidly (use-dependence or frequency-dependence), which is one reason pain fibres carrying a high-frequency barrage are blocked readily. At higher concentrations these drugs also block potassium and calcium channels and act on other targets, which contributes to toxicity.
Structure, onset, potency and duration
- pKa sets onset. The closer the pKa is to tissue pH, the greater the fraction present as the uncharged base and the faster the onset. Most agents have a pKa above 7.4, so the majority of the drug is ionised at physiological pH. Lignocaine, with a pKa near 7.8, acts faster than bupivacaine, with a pKa near 8.1. Adding bicarbonate raises local pH, increases the unionised fraction, speeds onset and reduces the sting of injection.
- Lipid solubility sets potency, because the drug must cross the nerve membrane and the surrounding myelin and connective tissue. Bupivacaine and ropivacaine are far more lipid soluble, and far more potent, than lignocaine.
- Protein binding (mainly to alpha-1 acid glycoprotein) sets duration, by holding the drug near the channel and slowing its removal. Local vasoactivity also matters: most of these drugs are vasodilators, which speeds their own removal, while ropivacaine is less so and cocaine is a vasoconstrictor.
- Blood flow at the site determines how fast the drug leaves the tissue and so both duration and peak plasma concentration: absorption is fastest from mucosal and intercostal sites and slowest from subcutaneous fat.
- Tissue acidosis (abscess, inflamed tissue) traps the drug outside the cell as the cation, so blocks fail or are slow. Infiltrating infected tissue also hurts more and can spread infection, which is a further argument for a regional block proximal to the problem.
Esters and amides
- Esters (procaine, benzocaine, tetracaine, cocaine; one "i" in the name) are hydrolysed in plasma by pseudocholinesterase, so their half-lives are very short and they are prolonged in pseudocholinesterase deficiency. Their metabolite para-aminobenzoic acid accounts for most true allergy to local anaesthetics.
- Amides (lignocaine, bupivacaine, ropivacaine, prilocaine, articaine; two "i" sounds) are metabolised in the liver by cytochrome P450 enzymes. Clearance falls in hepatic disease, in heart failure with reduced hepatic blood flow and with enzyme inhibitors; lignocaine is a high-extraction drug, so its clearance is flow-dependent.
- True allergy is rare. Most reported reactions are vasovagal, a response to added adrenaline, or to preservatives such as methylparaben. Cross-reactivity between the two classes is not expected.
- Cocaine is the exception in its class: it blocks sodium channels and also blocks noradrenaline reuptake, so it causes vasoconstriction, hypertension, tachycardia and coronary spasm.
Differential block and adjuncts
- Small, myelinated and rapidly firing fibres are blocked before large, thickly myelinated ones. In practice the order of loss is roughly autonomic, then pain and temperature, then touch, then pressure, then motor, and recovery runs in reverse. This is why a patient can feel pressure but not pain, and why a spinal block causes hypotension through early sympathetic blockade.
- Block requires a critical length of nerve to be exposed, which is why the node of Ranvier spacing in myelinated fibres and the volume and concentration of the injected solution both matter.
- Adrenaline added to a solution causes local vasoconstriction, which slows absorption, prolongs the block and reduces the peak plasma concentration; it also provides a marker of intravascular injection. The classic teaching that it must be avoided in digits and the nose has been substantially revised, but follow local policy, and avoid it where vasoconstriction is genuinely dangerous.
- Other adjuncts work by separate mechanisms: bicarbonate (speeds onset), dexamethasone and clonidine or dexmedetomidine (prolong blocks), hyaluronidase (spreads the solution), and liposomal formulations (slow release).
- Topical preparations rely on penetration: a eutectic mixture lowers the melting point so a high proportion of free base can diffuse through intact skin, while cocaine or lignocaine with adrenaline works well on mucosa and open wounds. Onset through intact skin is slow, so they must be applied early in the patient journey.
- Prilocaine and benzocaine can cause methaemoglobinaemia: a metabolite oxidises ferrous to ferric haem, which cannot carry oxygen and shifts the dissociation curve left. Saturation reads low and does not improve with oxygen; methylene blue is the specific antidote, acting through an alternative reductase pathway, and is contraindicated in glucose-6-phosphate dehydrogenase deficiency.
Systemic toxicity
Toxicity follows an excessive plasma concentration, from inadvertent intravascular injection, too large a quantity, or absorption from a vascular site. The risk depends on the agent, the site, the technique and the patient; the quantity considered safe differs between agents and is weight-based, so check the Australian Medicines Handbook or your local protocol rather than relying on memory.
Central nervous system effects come first because inhibitory interneurones are blocked before excitatory ones: perioral tingling, metallic taste, tinnitus, light-headedness and confusion, then muscle twitching and seizures, then depression of consciousness and respiration.
Cardiovascular toxicity follows, through sodium channel blockade in the conducting system and myocardium (a widened QRS, bradycardia, reduced contractility) and vasodilatation. Bupivacaine is the most cardiotoxic of the common agents: it binds cardiac sodium channels with high affinity and dissociates slowly, which favours re-entry and makes arrest very hard to reverse. Ropivacaine and levobupivacaine, the single enantiomers, were developed because their cardiac affinity is lower.
The treatment principles are prevention (aspiration, incremental injection, ultrasound guidance, a test dose, lowest effective quantity), early recognition, stopping the injection, airway and oxygenation, seizure control with a benzodiazepine, and intravenous lipid emulsion. The lipid is thought to act as a circulating lipid sink that draws the highly lipophilic drug away from the myocardium, and possibly to provide myocardial fuel and to affect channel function directly. Resuscitation may need to be prolonged because the drug must redistribute; follow your local protocol for the regimen.
Making the answer flow
- Lead with the two forms of the molecule: the base crosses, the cation blocks. Almost every other property follows from that.
- Link each physicochemical property to one clinical property: pKa to onset, lipid solubility to potency, protein binding to duration.
- Explain why a block fails in an abscess in terms of pH and ionisation.
- For toxicity, give the sequence (central then cardiac), say why bupivacaine is worse, then give the principles of management, including the lipid sink.
Where marks are lost
- Saying the charged form crosses the membrane, or that the uncharged form blocks the channel.
- Claiming local anaesthetics change the resting membrane potential.
- Saying esters are metabolised in the liver, or that cross-allergy between esters and amides is expected.
- Forgetting that a normal oxygen saturation can be wrong in methaemoglobinaemia.
- Treating a local anaesthetic cardiac arrest as a routine arrest and stopping resuscitation early.
Where this meets anaesthesia
- Local anaesthetic systemic toxicity may present with neurological symptoms or cardiovascular collapse; lipid emulsion is given early alongside standard resuscitation.
- Adding adrenaline to a local anaesthetic reduces absorption, prolongs the block and helps identify intravascular injection.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
How do local anaesthetics work?
Show answer
- Weak bases that block voltage-gated sodium channels from the inner face of the pore.
- Uncharged base crosses the membrane; cation binds the channel.
- Prevents the inward sodium current, so threshold is not reached and conduction fails.
- State-dependent: higher affinity for open and inactivated channels, giving use-dependence.
- Resting membrane potential is unchanged.
- 2.
Which properties determine onset, potency and duration?
Show answer
- pKa: the lower the pKa relative to tissue pH, the more unionised base and the faster the onset.
- Lipid solubility: greater solubility, greater potency.
- Protein binding: greater binding, longer duration; local vasoactivity and tissue blood flow also matter.
- Added vasoconstrictor prolongs duration and lowers peak plasma concentration.
- 3.
Why might a local anaesthetic fail to work in an infected finger?
Show answer
- Inflamed tissue is acidic, so more drug is ionised and less base crosses the membrane.
- Hyperaemia removes drug faster, and oedema dilutes and disperses it.
- Inflammatory mediators sensitise nociceptors and lower their threshold.
- Solution: block proximally in normal tissue, or use a regional technique.
- 4.
Compare esters and amides.
Show answer
- Esters: plasma pseudocholinesterase hydrolysis, short half-life, para-aminobenzoic acid metabolite causing most true allergy.
- Amides: hepatic cytochrome P450 metabolism, longer half-life, accumulation in liver disease and low hepatic flow.
- Lignocaine clearance is flow-dependent, so it falls in heart failure.
- Naming clue: two "i" sounds in amides.
- 5.
Describe the features of local anaesthetic systemic toxicity.
Show answer
- Early: perioral tingling, metallic taste, tinnitus, visual disturbance, agitation, confusion.
- Then muscle twitching and seizures, then coma and respiratory depression.
- Cardiovascular: QRS widening, bradycardia, arrhythmia, reduced contractility, vasodilatation, arrest.
- Risk factors: intravascular injection, vascular site, excessive quantity, acidosis, hypoxia, low protein binding states, extremes of age.
- 6.
Why is bupivacaine more cardiotoxic than lignocaine, and what is the role of lipid emulsion?
Show answer
- Higher affinity for cardiac sodium channels with slow dissociation, favouring re-entry and refractory arrest.
- Greater lipid solubility and protein binding; narrower margin between central and cardiac toxicity.
- Single enantiomers, ropivacaine and levobupivacaine, were developed to reduce this.
- Lipid emulsion acts as a lipid sink drawing the drug from the myocardium, may provide myocardial fuel; resuscitation must be prolonged while the drug redistributes.
- 7.
What is differential nerve blockade?
Show answer
- Small myelinated and rapidly firing fibres are blocked before large myelinated fibres.
- Clinical order of loss: autonomic, pain and temperature, touch, pressure, motor; recovery in reverse.
- Explains sympathetic blockade and hypotension in spinal anaesthesia, and retained pressure sensation during an adequate block.
- Also depends on exposure of a critical nerve length and the concentration applied.
- 8.
How does prilocaine cause methaemoglobinaemia and how is it treated?
Show answer
- Metabolite oxidises haem iron from ferrous to ferric, which cannot bind oxygen and shifts the curve left.
- Cyanosis unresponsive to oxygen, saturation gap between pulse oximetry and measured oxygen, chocolate-brown blood, co-oximetry diagnostic.
- Methylene blue accelerates reduction back to haemoglobin through an alternative reductase pathway.
- Avoid methylene blue in glucose-6-phosphate dehydrogenase deficiency and with serotonergic drugs; ascorbic acid and exchange transfusion are alternatives.
- 9.
Why is adrenaline added to local anaesthetic solutions, and what are the drawbacks?
Show answer
- Local vasoconstriction slows systemic absorption, prolongs the block, improves the surgical field and lowers peak plasma concentration.
- Also acts as a marker of intravascular injection.
- Drawbacks: systemic effects such as tachycardia and anxiety, tissue ischaemia where perfusion is marginal, and caution in severe cardiovascular disease.
- Older absolute cautions about digits have been revised, but follow local policy.
Practise this week
- Primary MCQs: pharmacology
- Primary SAQs, marked part by part
- Primary vivas
- Viva Examiner: practise answering aloud
Week 14 in the other subjects
- Physiology: Renal blood flow, GFR and clearance
Not affiliated with the Australian and New Zealand College of Anaesthetists (ANZCA). Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.